Comments
Loading...

Eli Lilly Analyst Ratings

LLYNYSE
Logo brought to you by Benzinga Data
$713.71
-1.49-0.21%
At close: -
$714.00
0.290.04%
After Hours: May 23, 7:59 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$1190.00
Lowest Price Target1
$610.00
Consensus Price Target1
$958.30

Eli Lilly Analyst Ratings and Price Targets | NYSE:LLY | Benzinga

Eli Lilly and Co has a consensus price target of $958.3 based on the ratings of 28 analysts. The high is $1190 issued by Citigroup on January 28, 2025. The low is $610 issued by Daiwa Capital on December 21, 2023. The 3 most-recent analyst ratings were released by UBS, HSBC, and Cantor Fitzgerald on May 2, 2025, April 28, 2025, and April 22, 2025, respectively. With an average price target of $908.33 between UBS, HSBC, and Cantor Fitzgerald, there's an implied 27.22% upside for Eli Lilly and Co from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
1
Mar
4
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
HSBC
Cantor Fitzgerald
Guggenheim
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Eli Lilly

Buy NowGet Alert
05/02/2025Buy Now47.06%UBS
Trung Huynh66%
$1100 → $1050MaintainsBuyGet Alert
04/28/2025Buy Now-1.96%HSBC
Rajesh Kumar61%
$1150 → $700DowngradeBuy → ReduceGet Alert
04/22/2025Buy Now36.55%Cantor Fitzgerald
Carter Gould57%
→ $975Initiates → OverweightGet Alert
04/14/2025Buy Now29.97%Guggenheim
Seamus Fernandez60%
$973 → $928MaintainsBuyGet Alert
04/09/2025Buy Now57.42%Morgan Stanley
Terence Flynn64%
$1146 → $1124MaintainsOverweightGet Alert
04/08/2025Buy Now24.37%Goldman Sachs
Asad Haider 37%
$892 → $888UpgradeNeutral → BuyGet Alert
03/05/2025Buy Now54.06%Wells Fargo
Mohit Bansal67%
$970 → $1100MaintainsOverweightGet Alert
02/03/2025Buy Now45.38%Truist Securities
Srikripa Devarakonda44%
$1029 → $1038MaintainsBuyGet Alert
01/28/2025Buy Now35.85%Wells Fargo
Mohit Bansal67%
$1000 → $970MaintainsOverweightGet Alert
01/28/2025Buy Now66.67%Citigroup
Peter Verdult13%
$1250 → $1190MaintainsBuyGet Alert
12/10/2024Buy Now39.64%B of A Securities
Tim Anderson61%
→ $997Reinstates → BuyGet Alert
11/15/2024Buy Now40.06%Wolfe Research
Alexandria Hammond42%
→ $1000Initiates → OutperformGet Alert
11/04/2024Buy Now42.16%Deutsche Bank
James Shin34%
$1025 → $1015MaintainsBuyGet Alert
10/31/2024Buy Now36.55%Barclays
Carter Gould57%
$1025 → $975MaintainsOverweightGet Alert
10/31/2024Buy Now54.06%B of A Securities
Geoff Meacham61%
$1150 → $1100MaintainsBuyGet Alert
10/25/2024Buy Now75.07%Citigroup
Peter Verdult13%
$1060 → $1250MaintainsBuyGet Alert
10/17/2024Buy Now54.06%Bernstein → $1100Initiates → OutperformGet Alert
10/10/2024Buy Now44.68%Truist Securities
Srikripa Devarakonda44%
$1000 → $1033MaintainsBuyGet Alert
10/03/2024Buy Now43.56%Deutsche Bank
James Shin34%
$1025 → $1025ReiteratesBuy → BuyGet Alert
09/16/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
09/13/2024Buy Now54.06%JP Morgan
Chris Schott59%
$1050 → $1100MaintainsOverweightGet Alert
09/13/2024Buy Now48.46%Citigroup
Peter Verdult13%
→ $1060ReinstatesBuy → BuyGet Alert
09/09/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
08/27/2024Buy Now54.9%Morgan Stanley
Terence Flynn64%
$1106 → $1106ReiteratesOverweight → OverweightGet Alert
08/19/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
08/16/2024Buy Now44.26%Guggenheim
Seamus Fernandez60%
$884 → $1030MaintainsBuyGet Alert
08/14/2024Buy Now47.06%Berenberg
Kerry Holford54%
$1000 → $1050MaintainsBuyGet Alert
08/12/2024Buy Now43.56%Deutsche Bank
James Shin34%
$725 → $1025UpgradeHold → BuyGet Alert
08/09/2024Buy Now40.06%Wells Fargo
Mohit Bansal67%
$875 → $1000MaintainsOverweightGet Alert
08/09/2024Buy Now54.2%BMO Capital
Evan Seigerman63%
$1001 → $1101MaintainsOutperformGet Alert
08/09/2024Buy Now57.56%B of A Securities
Geoff Meacham61%
$1000 → $1125MaintainsBuyGet Alert
08/05/2024Buy Now23.81%Guggenheim
Seamus Fernandez60%
$855 → $884MaintainsBuyGet Alert
08/05/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
07/24/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
07/15/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
07/11/2024Buy Now40.06%Berenberg
Kerry Holford54%
$850 → $1000MaintainsBuyGet Alert
07/11/2024Buy Now40.06%JP Morgan
Chris Schott59%
$900 → $1000MaintainsOverweightGet Alert
07/10/2024Buy Now43.56%Barclays
Carter Gould57%
$913 → $1025MaintainsOverweightGet Alert
07/05/2024Buy Now43.28%Morgan Stanley
Terence Flynn64%
$1023 → $1023MaintainsOverweightGet Alert
07/03/2024Buy Now40.2%BMO Capital
Evan Seigerman63%
$1001 → $1001MaintainsOutperformGet Alert
07/01/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/26/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy Now40.06%Truist Securities
Srikripa Devarakonda44%
$892 → $1000ReiteratesBuy → BuyGet Alert
06/24/2024Buy Now42.16%Jefferies
Akash Tewari41%
$994 → $1015MaintainsBuyGet Alert
06/24/2024Buy Now40.06%B of A Securities
Geoff Meacham61%
$1000 → $1000MaintainsBuyGet Alert
06/24/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/20/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/12/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/11/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/07/2024Buy Now34.03%Jefferies
Akash Tewari41%
$925 → $957MaintainsBuyGet Alert
05/14/2024Buy Now17.65%Argus Research
David Toung69%
$770 → $840MaintainsBuyGet Alert
05/01/2024Buy Now40.2%BMO Capital
Evan Seigerman63%
$900 → $1001MaintainsOutperformGet Alert
05/01/2024Buy Now26.05%JP Morgan
Chris Schott59%
$850 → $900MaintainsOverweightGet Alert
05/01/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$815 → $885MaintainsOverweightGet Alert
05/01/2024Buy Now24.93%Truist Securities
Srikripa Devarakonda44%
$850 → $892MaintainsBuyGet Alert
04/30/2024Buy Now23.95%Cantor Fitzgerald
Louise Chen53%
$815 → $885ReiteratesOverweight → OverweightGet Alert
04/18/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$815 → $815ReiteratesOverweight → OverweightGet Alert
04/15/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$815 → $815ReiteratesOverweight → OverweightGet Alert
04/11/2024Buy Now1.26%Goldman Sachs
Chris Shibutani55%
$650 → $723MaintainsNeutralGet Alert
04/05/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$815 → $815ReiteratesOverweight → OverweightGet Alert
04/03/2024Buy NowErste Group
Hans Engel64%
UpgradeHold → BuyGet Alert
04/02/2024Buy Now25.35%Citigroup
Andrew Baum69%
$675 → $895MaintainsBuyGet Alert
04/01/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$815 → $815ReiteratesOverweight → OverweightGet Alert
03/22/2024Buy Now19.05%Truist Securities
Robyn Karnauskas54%
→ $850ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now19.05%JP Morgan
Chris Schott59%
$775 → $850MaintainsOverweightGet Alert
03/01/2024Buy Now40.06%B of A Securities
Geoff Meacham61%
$800 → $1000MaintainsBuyGet Alert
02/21/2024Buy Now14.85%DZ Bank
Elmar Kraus68%
→ $820DowngradeBuy → HoldGet Alert
02/20/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$815 → $815ReiteratesOverweight → OverweightGet Alert
02/16/2024Buy Now33.05%Morgan Stanley
Terence Flynn64%
$805 → $950MaintainsOverweightGet Alert
02/14/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$815 → $815ReiteratesOverweight → OverweightGet Alert
02/07/2024Buy Now13.45%Barclays
Carter Gould57%
$680 → $810MaintainsOverweightGet Alert
02/07/2024Buy Now19.05%Truist Securities
Robyn Karnauskas54%
$650 → $850MaintainsBuyGet Alert
02/07/2024Buy Now12.75%Morgan Stanley
David Phung73%
$763 → $805MaintainsOverweightGet Alert
02/07/2024Buy Now15.55%Wells Fargo
Mohit Bansal67%
$700 → $825MaintainsOverweightGet Alert
02/07/2024Buy Now21.15%BMO Capital
Evan Seigerman63%
$710 → $865MaintainsOutperformGet Alert
02/06/2024Buy Now15.55%Wells Fargo
Mohit Bansal67%
$700 → $825MaintainsOverweightGet Alert
02/06/2024Buy Now14.15%Cantor Fitzgerald
Louise Chen53%
$630 → $815MaintainsOverweightGet Alert
02/05/2024Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
02/01/2024Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
$630 → $630ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy Now-1.96%Wells Fargo
Mohit Bansal67%
$650 → $700MaintainsOverweightGet Alert
01/23/2024Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
$630 → $630ReiteratesOverweight → OverweightGet Alert
01/23/2024Buy Now-4.76%Barclays
Carter Gould57%
$630 → $680MaintainsOverweightGet Alert
12/21/2023Buy Now-14.57%Daiwa Capital
Eli Lilly68%
→ $610DowngradeBuy → OutperformGet Alert
11/29/2023Buy Now-8.96%Truist Securities
Robyn Karnauskas54%
→ $650ReiteratesBuy → BuyGet Alert
11/20/2023Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
11/17/2023Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
11/15/2023Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
11/09/2023Buy Now-25.07%Deutsche Bank
James Shin34%
→ $535Initiates → HoldGet Alert
11/08/2023Buy NowJP Morgan
Chris Schott59%
Reiterates → OverweightGet Alert
11/03/2023Buy Now1.12%Morgan Stanley
David Phung73%
$673 → $722MaintainsOverweightGet Alert
10/23/2023Buy Now-5.46%Citigroup
Andrew Baum69%
$525 → $675MaintainsBuyGet Alert
10/23/2023Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
10/20/2023Buy Now-0.56%UBS
Trung Huynh66%
$612 → $710AssumesBuy → BuyGet Alert
10/11/2023Buy Now-5.74%Morgan Stanley
David Phung73%
$640 → $673MaintainsOverweightGet Alert
10/09/2023Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
10/09/2023Buy Now-8.96%Wells Fargo
Mohit Bansal67%
$615 → $650MaintainsOverweightGet Alert
10/02/2023Buy Now-11.76%Cantor Fitzgerald
Louise Chen53%
→ $630ReiteratesOverweight → OverweightGet Alert
09/05/2023Buy Now-13.17%Argus Research
David Toung69%
$470 → $620MaintainsBuyGet Alert

FAQ

Q

What is the target price for Eli Lilly (LLY) stock?

A

The latest price target for Eli Lilly (NYSE:LLY) was reported by UBS on May 2, 2025. The analyst firm set a price target for $1050.00 expecting LLY to rise to within 12 months (a possible 47.06% upside). 52 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Eli Lilly (LLY)?

A

The latest analyst rating for Eli Lilly (NYSE:LLY) was provided by UBS, and Eli Lilly maintained their buy rating.

Q

When was the last upgrade for Eli Lilly (LLY)?

A

The last upgrade for Eli Lilly and Co happened on April 8, 2025 when Goldman Sachs raised their price target to $888. Goldman Sachs previously had a neutral for Eli Lilly and Co.

Q

When was the last downgrade for Eli Lilly (LLY)?

A

The last downgrade for Eli Lilly and Co happened on April 28, 2025 when HSBC changed their price target from $1150 to $700 for Eli Lilly and Co.

Q

When is the next analyst rating going to be posted or updated for Eli Lilly (LLY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eli Lilly, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eli Lilly was filed on May 2, 2025 so you should expect the next rating to be made available sometime around May 2, 2026.

Q

Is the Analyst Rating Eli Lilly (LLY) correct?

A

While ratings are subjective and will change, the latest Eli Lilly (LLY) rating was a maintained with a price target of $1100.00 to $1050.00. The current price Eli Lilly (LLY) is trading at is $714.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch